A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 …
发布时间：2019-05-13 分享到：
Abstract. CD133 is a pivotal marker of cancer stem cells (CSCs), which is involved in tumorigenesis and cancer progression. Recent studies have identified CD1.
上一篇：Promoter methylation of fas apoptotic inhibitory molecule 2 gene is associated with obesity and dyslipidaemia in Chinese children
下一篇：Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer
返回列表
相关推荐
- Increased osteogenesis in osteoporotic bone marrow stromal cells by ove2019-05-13
- Targeted P2X7R shRNA delivery attenuates sympathetic nerve sprouting an2019-05-13
- TNF-a (-238G/A and -308G/A) gene polymorphisms may not contribute to t2019-05-13
- Genetic polymorphisms in Sox17 associated with intracranial aneurysm in2019-05-13
- Association of ENAM, TUFT1, MMP13, IL1B, IL10 and IL1RN gene poly2019-05-13
- miR-509-3p enhances platinum drug sensitivity in ovarian cancer2019-05-13